The National Institute on Drug Abuse (NIDA) awarded a $239.2K firm fixed-price purchase order to Golie, LLC, a small business, on December 5, 2024, to provide graphic design, marketing strategy development, Institutional Review Board (IRB) coordination, social media management, and community engagement services supporting NIDA's Intramural Research Program (IRP) Clinical Research initiatives. The contract encompasses a 12-month base period (December 5, 2024 through December 4, 2025) and one...
The National Institute on Drug Abuse awarded a firm fixed-price purchase order to Rashid Adnan (UEI: LMD7VXK1MQV9) on March 6, 2020, with a ceiling value of $26,900. The contract, which was solicited without a set-aside designation, calls for the awardee to study the pathophysiology and develop related research deliverables, with work to be performed in Greenbelt, Maryland. The solicitation was posted on January 31, 2020, with a bid due date of February 14, 2020, and the contract ultimately...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1,570,341 purchase order to Antelope Flats, LLC to provide targeted participant marketing and advertising services in support of clinical research studies conducted by NIDA's Intramural Research Program. The solicitation sought proposals to develop customized recruitment strategies and campaigns for each protocol to enroll eligible research participants, including those with...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $696,693.16, was awarded to PPD Development LP, a global contract research organization (CRO), to provide PPD development site and study monitoring services. The contract has no set-aside designation and is part of several indefinite delivery...
This is a $25,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Kiipo CO., a self-certified small disadvantaged business. The contract is for custom digital biomarker exploration to support NIDA's Immediate Response Program (IRP) data processing and other ecological momentary assessment (EMA) and just-in-time adaptive intervention (JITAI) research activities. The contract does not have a set-aside designation and has...
The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $54,000.00 labor-hour purchase order contract to RPK Associates, LLC, a small business, for pharmaceutics formulation and chemistry manufacturing and controls (CMC) consulting services for small molecules and/or biologics. The contract has a base period from September 20, 2025, through September 19, 2026, with optional hours up to 800 total hours per consultant annually. The services...
This is a federal contract award by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract, valued at $36,959.65, is a Firm Fixed Price Delivery Order under the NIH Long-Term Administrative Support Contract II (LTASC II) vehicle. The contract is for administrative support services, including recruitment, during the period of performance from September 1, 2020 to August 31, 2021. The...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Extendmr LLC, a minority-owned, self-certified small disadvantaged business. The contract has a ceiling value of $27,500.00 and a performance period ending on September 29, 2026. The contract was awarded on September 30, 2025 and does not have a set-aside designation. No information was provided about a larger contract vehicle or subcontractors. The contract is for...
The National Institute on Drug Abuse (NIDA) awarded a delivery order valued at $415,717 to Technical Resources International, Inc. (TRI), a minority-owned and woman-owned small business based in Bethesda, Maryland, for a Phase I Single Ascending Dose Study under the Pharmacokinetic Analysis Resource Center program. The contract, awarded on September 10, 2024, with an ultimate completion date of March 8, 2027, represents a cost-plus-fixed-fee engagement. This delivery order was issued under...
The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $16,000 purchase order to Cellx, Inc., a small business, on September 29, 2025, for pharmaceutics formulation, chemistry manufacturing and controls (CMC) consulting services supporting drug discovery and development programs. The contract, which runs through September 28, 2028, provides specialized subject matter expert consultation for small molecules and biologics development, with...
This is a purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Hope Health Systems, Inc., a minority-owned small business, for grassroots outreach and community partnership services to support participant recruitment for the NIDA Intramural Research Program (NIDA IRP) clinical studies. The contract has a period of performance from September 29, 2020 to June 28, 2021, with a ceiling value of $23,486.61. It is not a set-aside contract. The original sources sought notice indicated NIDA IRP's mission to conduct research on substance use disorders and develop new treatment methods, utilizing volunteer human participants in residential and non-residential studies. The contract is intended to provide community engagement and participant recruitment services to support this research program.